NM_000135.4:c.317G>C
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_000135.4(FANCA):c.317G>C(p.Gly106Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000366 in 1,613,944 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G106E) has been classified as Uncertain significance.
Frequency
Consequence
NM_000135.4 missense
Scores
Clinical Significance
Conservation
Publications
- Fanconi anemia complementation group AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
 - Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| FANCA | NM_000135.4  | c.317G>C | p.Gly106Ala | missense_variant | Exon 4 of 43 | ENST00000389301.8 | NP_000126.2 | |
| FANCA | NM_001286167.3  | c.317G>C | p.Gly106Ala | missense_variant | Exon 4 of 43 | NP_001273096.1 | ||
| FANCA | NM_001018112.3  | c.317G>C | p.Gly106Ala | missense_variant | Exon 4 of 11 | NP_001018122.1 | ||
| FANCA | NM_001351830.2  | c.317G>C | p.Gly106Ala | missense_variant | Exon 4 of 10 | NP_001338759.1 | 
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0000197  AC: 3AN: 152218Hom.:  0  Cov.: 33 show subpopulations 
GnomAD2 exomes  AF:  0.0000717  AC: 18AN: 251016 AF XY:  0.0000810   show subpopulations 
GnomAD4 exome  AF:  0.0000383  AC: 56AN: 1461726Hom.:  0  Cov.: 31 AF XY:  0.0000495  AC XY: 36AN XY: 727138 show subpopulations 
Age Distribution
GnomAD4 genome   AF:  0.0000197  AC: 3AN: 152218Hom.:  0  Cov.: 33 AF XY:  0.0000403  AC XY: 3AN XY: 74366 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Fanconi anemia    Uncertain:2 
This sequence change replaces glycine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 106 of the FANCA protein (p.Gly106Ala). This variant is present in population databases (rs764893807, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with FANCA-related conditions. ClinVar contains an entry for this variant (Variation ID: 456110). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FANCA protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
Fanconi anemia complementation group A    Uncertain:2 
This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
- -
Inborn genetic diseases    Uncertain:1 
The p.G106A variant (also known as c.317G>C), located in coding exon 4 of the FANCA gene, results from a G to C substitution at nucleotide position 317. The glycine at codon 106 is replaced by alanine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at